According to GlaxoSmithKline's latest financial reports the company's current earnings are A$42.35 Billion. In 2024 the company made an earning of A$6.60 Billion a decrease over its 2023 earnings that were of A$11.35 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.